Life Science Compliance Update

March

2018

Transforming Health Care in the Middle Kingdom – China’s New Medical Representative Regulation

Written by , Posted in Uncategorized

Gwendolyn Ball, Staff Writer, Life Science Compliance Update

China is the world’s largest and perhaps most complex economy. As the PRC emerges the world stage, it continues to transform its health care system. This article examines the nature of some of the regulatory reforms impacting the pharmaceutical industry with particular focus on the new medical representative requirements.


   or   


Menu Title